China Disease Control: China's vaccine adverse reaction monitoring indicators have reached or exceeded WHO evaluation standards

　　China News Service, Beijing, January 3 (Reporter Du Yan) On January 3, the Information Office of the Beijing Municipal People's Government held the 200th regular press conference on epidemic prevention and control.

Wang Huaqing, chief expert of the China Centers for Disease Control and Prevention’s immunization program, said at a press conference held today that the country has promulgated relevant laws and regulations, and has also established a team composed of disease control agency personnel to do this work. An adverse reaction electronic information system to realize data sharing.

　　Who will report an adverse reaction?

Who will investigate?

Who will diagnose?

Who will identify?

　　Wang Huaqing said that there are relevant regulations in relevant laws and departmental regulations, and the responsible reporter will report.

　　He said that for the reporting time limit of adverse reactions, it is stipulated that the report should be carried out within 2 hours for particularly serious adverse reactions, and within 48 hours in general.

　　Is it an adverse reaction caused by the vaccine?

Wang Huaqing said that the diagnosis is done by the investigation and diagnosis teams set up at the provincial, municipal and county levels of disease control institutions. If identification is needed, the provincial and municipal medical associations will complete the diagnosis.

　　He said that the monitoring of suspected vaccine adverse reactions is achieved through the monitoring information system established by the China Centers for Disease Control and Prevention, and the CDC and adverse drug reaction monitoring institutions realize information sharing.

Disease control agencies and adverse drug reaction monitoring agencies at all levels will also regularly analyze and evaluate the monitored information.

In case of major incidents, timely analysis and evaluation will be conducted.

　　He said that China's standardized monitoring of vaccine adverse reactions started in 2005.

With the in-depth development of work, the level of vaccine adverse reaction monitoring has been greatly improved.

In 2011 and 2014, respectively, through the World Health Organization's capacity assessment of the adverse reaction monitoring part of China's national vaccine regulatory system, the monitoring indicators for vaccine adverse reactions met or exceeded the evaluation standards of the World Health Organization.